Prosolus pharmaceuticals

Mission Pharmacal Acquires ProSolus Pharmaceuticals

Acquisition adds cutting-edge expertise in transdermal drug development and manufacturing SAN ANTONIO, TX — Effective May 29, 2015, Mission Pharmacal Company (“Mission”) has acquired the assets of ProSolus Pharmaceuticals LP headquartered in Miami, Fla. Mission’s wholly-owned subsidiary, ProSolus Inc., offers unrivaled expertise in the development and manufacturing of sophisticated and convenient transdermal (through the skin) drug…